On the first day of the bidding process, Emcure Pharmaceuticals Limited IPO was subscribed 1.32 times. The retail portion was subscribed to 1.41x, 0.07x in Qualified Institutional Buyers (QIB), 2.76x in Non-Institutional Investors (NII), and 2.25x in the employees category. The IPO opened today, July 3, 2024, and will close on July 5, 2024. The …